The goal of this clinical trial is to compare a new way of using magnetic resonance-guided adaptive radiation therapy (MRgART) to the standard of care linear a…

Non-Small Cell Lung Cancer (Stage III)Esophageal Cancer Stage I-IIIEsophagogastric Cancer Stage I-III+2 more

~Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT07132918

Phase 2

A Phase II Study of Neoadjuvant NAPOX Followed by Chemoradiation With Paclitaxel and Carboplatin in Locally Advanced Esophagogastric Cancer

In this research study, is studying how Liposomal Irinotecan in combination with the standard of care interventions FOLFOX, carboplatin paclitaxel, and radiati…

Gastroesophageal Junction AdenocarcinomaEsophagogastric Cancer

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT04656041